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A B S T R A C T
Background: Historically, semi-closed populations have had high rates of meningococcal carriage and
have experienced recurrent outbreaks. As such, these high-risk groups are recommended for targeted
vaccination in many countries.
Methods: A systematic review of eight databases and Google Scholar forward citations was conducted to
characterize serogroup-speciﬁc meningococcal carriage in university students, military personnel, and
Hajj pilgrims from 2007 to 2016.
Results: A total of 7014 records were identiﬁed and 22 studies were included. Overall carriage ranged from
0.0% to 27.4% in Hajj pilgrims, from 1.5% to 71.1% in university students, and from 4.2% to 15.2% in military
personnel. Among serogroups A, B, C, W, X, and Y, serogroup B was most prevalent in Hajj pilgrims, B and
Y in university students, and B, C, and Y in military personnel. ‘Other’ serogroups were more prevalent in
university students than Hajj pilgrims or military personnel. Risk factors for carriage varied by setting.
Among Hajj pilgrims, a high endemicity in the country of origin increased the risk of carriage, while
smoking, male sex, and frequently attending parties increased the carriage risk for university students.
Similarly, smoking increased the carriage risk for professional soldiers. Data gaps remain for many
regions.
Conclusions: Preventative vaccination policies for high-risk groups should be based on current
disease data in individual countries, supplemented by carriage data. Meningococcal carriage studies
and disease surveillance are critical for determining the local epidemiology, populations responsible for
disease transmission, and the need for targeted vaccination.
© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Invasive meningococcal disease (IMD) is a severe bacterial
infection caused by Neisseria meningitidis, a Gram-negative
bacterium often carried harmlessly in the pharynx of humans.
IMD commonly presents as meningitis and septicaemia, but can
more rarely cause diseases such as septic arthritis and pericarditis
(Pace and Pollard, 2012). Despite advances in medical care, IMD
case fatality is approximately 10–15%, and debilitating sequelae,
such as amputation and neurological impairment, can result from
infection in an estimated 10–15% of survivors (Pace and Pollard,
2012; Edmond et al., 2010). The incidence of IMD varies globally,
with the highest burden in the African meningitis belt, young
children and adolescents, and immunocompromised individuals* Corresponding author.
E-mail address: Meagan.Peterson@ed.ac.uk (M.E. Peterson).
1 Harish Nair and Moe H. Kyaw are joint authors in this position.
https://doi.org/10.1016/j.ijid.2018.05.022
1201-9712/© 2018 The Authors. Published by Elsevier Ltd on behalf of International Soc
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(Harrison et al., 2009; McNamara et al., 2017a; Snydman et al.,
2014; Jafri et al., 2013). Additionally, semi-closed populations are at
high risk of infection, with numerous outbreaks reported among
university students, Hajj/Umrah pilgrims, and military recruits
(Brundage et al., 2002; Jean-François et al., 2002; National
Foundation for Infectious Diseases (NFID), 2017). As such,
preventative vaccination programmes have been introduced in
these settings (National Foundation for Infectious Diseases (NFID),
2017; Yezli et al., 2016a; Michael et al., 2015).
Historically, carriage of the bacterium was estimated to occur in
approximately 10% of the general population, with most people
becoming a carrier multiple times in their lifetime (Cartwright
et al., 1987). Transmission of the meningococcus occurs through
droplet spread and thus through close contact with a carrier of
N. meningitidis or an infected individual. Studies estimate that
carriage peaks in early-to-late adolescence, depending on the
region (Cooper et al., 2017; Christensen et al., 2010), indicating
that persons of these ages are likely important transmitters of
disease. Social behaviours, recent respiratory infections, andiety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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carriage (MacLennan et al., 2006; Mueller et al., 2008).
Six of the 12 capsular groups of N. meningitidis—A, B, C, W, X, and
Y—cause the majority of disease cases, and their distribution varies
globally. There are vaccines currently available targeting ﬁve of the
12 meningococcal serogroups, i.e. A, B, C, W, and Y, although the ‘B’
vaccines include recombinant proteins or recombinant proteins
plus outer membrane vesicles, not capsular polysaccharides like
the other vaccines. While conjugate vaccines have induced herd
immunity for some serogroups, in part through a reduction in
carriage levels (Trotter and Maiden, 2009), it is as yet unclear
whether the broad-protection MenB vaccines will have similar
effects (Donnelly et al., 2010; Pajon et al., 2016). Knowledge of the
locally circulating serogroups and disease incidence is key for
appropriate vaccine recommendations.
Hitherto, reviews have focused on select regions/populations or
have provided prevalence-only carriage data, and an updated
carriage review is warranted (Soriano-Gabarro et al., 2011a; Trotter
and Greenwood, 2007; Agier et al., 2017; Zhang et al., 2007; Yezli
et al., 2016b). No review describing serogroup-speciﬁc carriage in
the three high-risk settings of university students, military
personnel, and Hajj/Umrah pilgrims at a global level could be
identiﬁed. Understanding the serogroups carried by high-risk
populations such as these is important in gaining a better
understanding of disease transmission and potential populations
for vaccination (Borrow et al., 2016; Vetter et al., 2016). Therefore,
the aim of this review was to summarize the carriage studies with
serogroup data conducted in these deﬁned high-risk settings for
the period 2007–2016.
Methods
Search strategy and data sources
A systematic review of the literature was conducted to identify
serogroup-speciﬁc meningococcal carriage studies conducted
between January 1, 2007 and December 31, 2016 in university
students, military personnel, or Hajj/Umrah pilgrims (PROSPERO
number CRD42017074671). Two authors (MEP and RM) searched
six databases (MEDLINE, Embase, Global Health Database, WHO
Global Health Library, Web of Science, Current Contents Connects)
in July 2017. Search terms were developed for MEDLINE
(Supplementary material, Table S1) and adapted for the remaining
databases. Two Chinese literature databases (CNKI and Wanfang)
were searched in June 2017 by a native speaker (YL), who
translated the Chinese search terms from the English version.
Google Scholar forward citations, relevant conference abstract
lists, and references of identiﬁed studies and reviews were also
searched. Forward searches on Google Scholar and conference
abstracts were searched again in January 2018 as an update. No
exclusion was made based upon language, and Google Translate
was used to assist in the screening of foreign language articles. If
questions remained, native speakers were contacted for assistance
in translation.
Inclusion and exclusion criteria
Studies were considered for inclusion if they reported
serogroup-speciﬁc pharyngeal carriage in asymptomatic indi-
viduals in a high-risk setting (Hajj/Umrah pilgrimage, universi-
ty, or military), provided a clear geographic location for the
participants, and were sampled only from the setting in
question.
Studies were not eligible for inclusion if they were not in
humans, only provided disease data, were carriage studies among
cases or close-contacts of cases, only reported secondary data,were case studies, commentaries, or reviews, did not specify the
geographic location or included global samples together, had
unclear reporting of serogroups or participants sampled, only
tested for one serogroup, could not be obtained and the author
could not be contacted, or serogrouped or reported less than 75% of
positive carriage specimens.
Data collection and management
Studies identiﬁed were imported into EndNote, where dupli-
cates were removed. Two authors (MEP and RM) independently
screened the titles and abstracts of all studies and the relevant
full-text articles from the English databases. Data from studies
selected for inclusion were independently extracted into Microsoft
Access by two authors (MEP and RM). One author screened the
Chinese articles (YL) with input from another (MEP). Any
disagreements in eligibility or extractions were discussed and a
consensus reached before moving forward.
Quality assessment
Studies identiﬁed for inclusion were assessed for quality using a
modiﬁed Joanna Briggs Institute Checklist for Prevalence Studies.
The quality of studies was ranked as high (0–3 no/unclear),
medium (4–6 no/unclear), or low (7–9 no/unclear).
Data analysis
A narrative synthesis was performed for identiﬁed studies.
Results were reported by high-risk setting and World Health
Organization (WHO) region. Meta-analyses of serogroup carriage
prevalence were deemed inappropriate due to heterogeneity
between study populations and settings and/or insufﬁcient data by
WHO region.
Results
A total of 7014 records were identiﬁed and 331 were screened in
full. Of these, 23 met the inclusion criteria (Figure 1). Three studies
were among Hajj pilgrims, 14 among university students, ﬁve
among military personnel, and one among university students and
military personnel. Ten studies sampled participants in the
high-risk settings of interest and reported serogroup-speciﬁc
carriage but did not meet other eligibility criteria (Supplementary
material, Table S2). Most studies received medium-level quality
scores, primarily due to underreporting of study or population
characteristics (Supplementary material, Table S3). Since no
methodological ‘gold standard’ exists for carriage studies, no
studies were excluded from the review based on quality scores.
Hajj pilgrims
Three studies among Hajj pilgrims met the inclusion criteria
(Azeem et al., 2017; Ceyhan et al., 2013; Memish et al., 2017), and
no eligible studies were conducted among Umrah pilgrims. Each of
the included studies investigated serogroup-speciﬁc carriage
among pilgrims both before and after the Hajj. However, the
location of the ‘before’ and ‘after’ time point was inconsistent
between studies and was a combination of swabbing pilgrims in
their home countries and/or while in Mina. In total, 2774 pilgrims
were sampled, representing 14 nationalities. One study included
was a cohort study among Turkish pilgrims in 2010 (Ceyhan et al.,
2013), while the other two studies were repeat cross-sectional
studies with a nested cohort, one among Australian pilgrims in
2014 and the other among pilgrims from 12 countries in 2014
(Azeem et al., 2017; Memish et al., 2017).
Records identified through other sources
(n = 26)
Records identified through database searching
(n = 6988)
Full-text articles assessed for eligibility (n =331)
Total records (n =7014)
Duplicates removed (n=3203)
Records screened (n =3811)
Excluded (n =308)
Pre-2007: 44
Subset or secondary analysis: 88
No meningococcal carriage or no 
serogroup data: 50
Overlapping data: 29
Ineligible carriage studies: 97
Records excluded because not relevant 
to topic (n =3480)
Total Included Studies (n =23)
Figure 1. PRISMA ﬂowchart of included studies.
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all pilgrims from two studies were vaccinated with the quadriva-
lent (ACWY) polysaccharide vaccine prior to the pilgrimage
(Ceyhan et al., 2013; Memish et al., 2017), while one study
reported approximately one-third of the pilgrims were vaccinated
with the quadrivalent conjugate vaccine (Azeem et al., 2017).
Chemoprophylaxis was given to pilgrims from countries of the
African meningitis belt upon arrival at the airport in Saudi Arabia.
Most participants were at least 18 years old.
Laboratory methods also varied between studies (Supplemen-
tary material, Table S4). The site of swabbing was inconsistent
between studies, with one using nasopharyngeal swabs (Memish
et al., 2017), one posterior pharyngeal swabs (Azeem et al., 2017),
and one both oropharyngeal and nasopharyngeal swabs (Ceyhan
et al., 2013). Only one study swabbed participants both prior to and
after vaccine administration (Ceyhan et al., 2013), while the other
two swabbed participants only after administration (Azeem et al.,
2017; Memish et al., 2017). PCR was used to identify the genogroup
in all studies. However, one study used slide agglutination (SASG)
to determine the ‘after’ pilgrimage serogroups (Azeem et al., 2017).
Carriage rates were typically below 5% (Azeem et al., 2017;
Memish et al., 2017), but carriage up to 27% was reported (Ceyhan
et al., 2013). Pilgrims from the Western Paciﬁc region had the
lowest carriage prevalence (before: 0.0–0.5%; after: 0.0–1.1%),
while Turkish pilgrims from the European region had the highest
(before: 13.4%; after: 27.4%). Serogroups A, B, W, Y, and non-
groupable were identiﬁed in at least one study, with serogroup B
being the most common in many regions (Table 1). In most cases,
when a serogroup was detected, the change in prevalence beforeand after the Hajj was not substantial (median 1.3%, mean 2.6%,
range 0.0–14.0%). The extent of acquisition was variable between
studies. No carriers were found among pilgrims from Albania or
India (Memish et al., 2017).
Only one study assessed risk factors associated with meningo-
coccal carriage among Hajj pilgrims (Supplementary material,
Table S7) (Memish et al., 2017). The only risk factor investigated in
that study was the endemicity of the country of origin and its effect
on carriage at arrival. Pilgrims from high endemic countries
(Ethiopia, Nigeria, and Tanzania) were found to have statistically
higher carriage rates upon arrival than pilgrims from other
countries (6.3% and 2.0%, respectively).
University students
Fifteen studies that sampled only university students met the
inclusion criteria. Six studies were cross-sectional studies (Aliyu
and Olayinka, 2017; Bali et al., 2017; Rizek et al., 2016; Rodrigues
et al., 2015; Rodriguez et al., 2014; Tryﬁnopoulou et al., 2016;
Takahashi et al., 2016), six were repeat cross-sectional studies with
a nested cohort (either intentional or unintentional) (Ala’aldeen
et al., 2011; Breakwell et al., 2018; Durey et al., 2012; McNamara
et al., 2017b; Oldﬁeld et al., 2017; Soeters et al., 2017), two were
cohort studies (Bidmos et al., 2011; Gilca et al., 2013), and one was a
randomized controlled trial investigating the impact of vaccination
on carriage (Read et al., 2014). The majority of studies were
conducted in the region of the Americas (n = 6) or the European
region (n = 6), and no study was identiﬁed from the Eastern
Mediterranean region. The sample size of the studies ranged from
Table 1
Serogroup-speciﬁc carriage prevalence in studies among Hajj pilgrimsa.
Country Year Number swabbed A B C W X Y NG/other Overall carriage
African Region
Ethiopia (Memish et al., 2017) 2014 Before: 93 4.3 – – – – 2.2 6.5
Before: 64* 4.7 ND ND ND ND 6.3
After: 64* – – – – – 0.0
Nigeria (Memish et al., 2017) 2014 Before: 85 – 5.9 – – – 10.6 16.5
Tanzania (Memish et al., 2017) 2014 Before: 95 – 1.1 – – – 1.1
Before: 72* – 1.4 – – – 1.4
After: 72* – 2.8 – – – 2.8
Region of the Americas
USA (Memish et al., 2017) 2014 Before: 92 – 2.2 – – – 2.2
Before: 40* – 2.5 – – – 2.5
After: 40* – 5.0 – – – 5.0
Eastern Mediterranean Region
Egypt (Memish et al., 2017) 2014 Before: 98 – 1.0 – – – 1.0
Before: 86* – 1.2 – – – 1.2
After: 86* – 1.2 – – – 1.2
Pakistan (Memish et al., 2017) 2014 Before: 98 – 1.0 – – – 1.0
Before: 89* – 1.1 – – 1.1
After: 89* – – – – 0.0
Somalia (Memish et al., 2017) 2014 Before: 98 – 6.1 – – – 1.0 7.1
Before: 50* ND 10.0 ND ND ND 12.0
After: 50* – 2.0 – – – 2.0
European Region
Turkey (Ceyhan et al., 2013) 2010 Before: 472* 0.2 1.9 – 11.0 – 0.2 – 13.4
After: 296* 0.3 1.7 – 25.0 – 0.3 27.4
South-East Asia Region
Bangladesh (Memish et al., 2017) 2014 Before: 79 – 2.5 – – – 2.5
Before: 27* – 3.7 – – – 3.7
After: 27* – 3.7 – – – 3.7
Indonesia (Memish et al., 2017) 2014 Before: 98 – 2.0 – – – 2.0
Before: 59* – 1.7 – – – 1.7
After: 59* – – – – – 0.0
Western Paciﬁc Region
Australia (Azeem et al., 2017) 2014 Before: 183* – – – 0.5 – 0.5
After: 93* – 1.1 – – – 1.1
Malaysia (Memish et al., 2017) 2014 Before: 95 – – – – – 0.0
Before: 68* – 1.5 – – – 1.5
After: 68* – – – – – 0.0
aIndividual serogroup prevalence may not sum to overall carriage due to rounding or if select serogroup results were not reported. NG: non-groupable. (*): includes
participants from a cohort or a nested cohort. (–): serogroup tested for but not identiﬁed (i.e., 0.0% prevalence). Blank: serogroup not tested for or testing of serogroup not
reported. (ND): serogroup tested for but not reported. The most prevalent group identiﬁed is shown in bold.
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commencing within the ﬁrst week of a new academic term and the
remainder at various points in the academic year.
As with studies in Hajj pilgrims, participant characteristics
varied between studies (Supplementary material, Table S5). For
example, high coverage rates of conjugate MenACWY and MenC
were reported in the USA and the UK, respectively. MenB-fHbp and
MenB-4C were used only among students in the USA. Most studies
did not have strict inclusion or exclusion criteria, but three studies
excluded participants for factors such as recent antibiotic use or a
previous history of meningococcal disease (Bali et al., 2017;
Rodriguez et al., 2014; Read et al., 2014). Where ages were
reported, the majority of studies included only students of typical
university age, about 18–26 years old (n = 6/7). The three studies in
the USA were conducted after recent serogroup B outbreaks at the
university but not as a means to determine the carriage among
close contacts of cases.
Although there were differences in methodologies between
studies, the swab sites and methods used to detect the capsulargroup in carriers were similar. Only one study described
swabbing the nasopharynx, while the remaining used pharyn-
geal swabs. All studies, except one, in university students used a
genotypic method such as PCR or whole genome sequencing to
categorize the genogroup in carriers. One study used SASG to
serogroup the positive results, but used multilocus sequence
typing for further characterization. Seven studies reported the
results from SASG and PCR testing, and PCR was universally
more sensitive.
Overall carriage rates varied substantially between studies and
regions, with the highest carriage in the region of the Americas
(range 4.0–71.1%) and European region (range 10.4–61.9%). At the
country level, the highest carriage rates among university
students were in England and ranged from 14.3% to 61.9%. Low
levels of carriage were identiﬁed in Chile (4.0%), Nigeria (5.1%),
and India (1.5%). Non-groupable, capsule null locus (cnl), or other
serogroups that are typically non-disease causing, were the most
commonly identiﬁed among carriers in most regions. Exceptions
included studies from Brazil, England, and India, where the most
M.E. Peterson et al. / International Journal of Infectious Diseases 73 (2018) 109–117 113prevalent capsular groups identiﬁed were C (46.3%), Y (21.1%), and
B (1.5%), respectively, at baseline (Table 2).
Seven studies assessed risk factors associated with increased
carriage among university students, the methodology of which is
detailed in Supplementary material Table S7 (Aliyu and Olayinka,
2017; Rodriguez et al., 2014; Tryﬁnopoulou et al., 2016; Breakwell
et al., 2018; Durey et al., 2012; McNamara et al., 2017b; Soeters
et al., 2017). Risk factors investigated included demographic data
and social behaviours, such as age, sex, smoking, recent respiratory
infections, and attending crowded social settings. Smoking, male
sex, and attending parties or clubs at least once per week were
most frequently reported as risk factors in the study populations.
Additional risk factors identiﬁed included recent upper respiratory
infection and age or graduation year representative of students
halfway through university. One study included both university
students and military recruits in their risk factor assessment
(Tryﬁnopoulou et al., 2016); therefore, these associations are not
reported as it cannot be determined which setting contributed to
the increased risk.Table 2
Serogroup-speciﬁc carriage prevalence in studies among university studentsa.
Country Year Number swabbed A 
African Region
Nigeria (Aliyu and Olayinka, 2017) 2014 336 0.9 
Region of the Americas
Brazil (Rizek et al., 2016) 2010 190 – 
Canada (Gilca et al., 2013) 2011–12 360* ND 
Chile (Rodriguez et al., 2014) 2012 500 – 
USA (Breakwell et al., 2018) 2015 1st: 1067* – 
2nd: 761* – 
USA (McNamara et al., 2017b) 2015–16 1st: 1173* – 
2nd: 1069* – 
3rd: 1045* – 
4th: 938* – 
USA (Soeters et al., 2017) 2015–16 1st: 717* – 
2nd: 878* – 
3rd: 622* – 
4th: 626* – 
European Region
England (Bidmos et al., 2011) 2008–09 1st: 190* – 
2nd: 91* – 
3rd: 74* – 
4th: 63* – 
England (Ala’aldeen et al., 2011) 2009–10 1st: 1585* ND 
2nd: 1049* ND 
3rd: 678* ND 
England (Read et al., 2014) 2010 1st: 2954* – 
England (Oldﬁeld et al., 2017) 2015–16 1st: 769* ND 
2nd: 353* ND 
3rd: 288* ND 
Greece (Tryﬁnopoulou et al., 2016) 2015 740 – 
Portugal (Rodrigues et al., 2015) 2012 601 – 
South-East Asia Region
India (Bali et al., 2017) 2014 274 – 
Western Paciﬁc Region
Republic of Korea (Durey et al., 2012) 2009 1st: 136* – 
2nd: 128* – 
aIndividual serogroup prevalence may not sum to overall carriage due to rounding o
participants from a cohort or a nested cohort. (–): serogroup tested for but not identiﬁe
reported. (ND): serogroup tested for but not reported. The most prevalent group identMilitary personnel
Five cross-sectional studies and one cross-sectional study with
nested cohorts conducted among military personnel met the
inclusion criteria, four of which were from the European region.
Four studies were among new recruits in Greece (Tryﬁnopoulou
et al., 2016), Iran (Ataee et al., 2016), Turkey (Celal Basustaoglu
et al., 2011), and the Republic of Korea 48 and two studies were
among professional soldiers in Poland (Korzeniewski et al., 2015;
Korzeniewski et al., 2017). Sample sizes ranged from 226 to 1995. In
the studies among new recruits, when reported, the initial time
point of swabbing varied from day 1 to day 7 after military
entrance; only one study swabbed recruits again to evaluate
changes in carriage (Heo et al., 2014).
Similar to the other high-risk settings in this review, study
participants differed between studies (Supplementary material,
Table S6). Three studies swabbed participants immediately prior to
or post-vaccine administration (Ataee et al., 2016; Celal Basus-
taoglu et al., 2011; Heo et al., 2014), and at least a portion of theB C W X Y NG/other Overall carriage
0.9 0.3 1.5 1.5 5.1
1.6 46.3 – – 20.5 71.1
6.9 ND ND ND ND ND 28.8
0.8 – 0.6 – 2.6 4.0
1.8 0.2 – 0.2 0.7 9.9 12.8
2.6 0.3 – 0.3 0.7 10.8 14.6
1.2 0.3 0.2 0.1 0.3 12.3 14.2
2.2 0.1 – 0.1 0.2 14.6 17.1
1.9 0.3 – – 0.3 8.0 10.5
2.3 0.1 0.1 – 0.5 14.3 17.4
4.3 1.1 – 0.1 0.4 18.4 24.4
4.1 0.3 – 0.2 0.5 18.9 24.0
4.2 – 0.2 – 0.2 15.3 19.8
3.5 – 0.2 0.8 0.3 16.0 20.8
6.3 0.5 1.1 0.5 21.1 17.4 46.8
4.4 1.1 – – 24.2 20.9 50.6
4.1 1.4 – – 24.3 25.7 55.4
7.9 1.6 3.2 – 25.4 23.8 61.9
8.0 ND ND ND 5.7 ND 27.8
9.3 ND ND ND 17.6 ND 46.3
10.9 ND ND ND 13.9 ND 48.7
9.4 0.3 1.7 6.9 32.6
3.3 ND 0.7 ND 1.8 5.3 14.3
8.5 ND 6.8 ND 2.3 11.6 38.5
5.9 ND 8.0 ND 3.8 17.8 46.2
3.4 – 0.7 0.5 1.9 3.9 10.4
5.3 0.3 0.2 0.2 1.7 5.7 13.3
1.5 – – – – 1.5
2.2 3.7 – – – 5.9 11.8
3.1 4.7 0.8 – – 5.5 14.1
r if select serogroup results were not reported. NG: non-groupable. (*): includes
d (i.e., 0.0% prevalence). Blank: serogroup not tested for or testing of serogroup not
iﬁed is shown in bold.
Table 3
Serogroup-speciﬁc carriage prevalence in studies among military personnela.
Country Year Number swabbed A B C W X Y NG/other Overall carriage
European Region
Greece (Tryﬁnopoulou et al., 2016) 2014 680 – 6.8 0.3 0.4 0.3 1.3 6.0 15.2
Poland (Korzeniewski et al., 2015) 2013 559 – 1.6 1.3 – 1.4 1.4 5.7
Poland (Korzeniewski et al., 2017) 2016 1246 – 2.7 0.5 0.2 0.5 1.4 5.2
Turkey (Celal Basustaoglu et al., 2011) 2008 1995 0.1 0.3 0.4 0.5 0.7 2.3 4.2
Eastern Mediterranean Region
Iran (Ataee et al., 2016) 2014–15 226 1.8 4.0 0.4 0.4 1.3 8.0
Western Paciﬁc Region
Republic of Korea (Heo et al., 2014) 2013–14 1st: 434* – 4.1 1.4 – – 0.2 3.2 9.0
2nd: 434* – 2.1 – 0.5 1.2 – 10.1 13.8
3rd: 443* – 2.5 3.8 0.2 0.2 – 5.9 12.6
4th: 443* – 1.4 0.9 0.2 – – 2.7 5.2
aIndividual serogroup prevalence may not sum to overall carriage due to rounding or if select serogroup results were not reported. NG: non-groupable. (*): includes
participants from a cohort or a nested cohort. (–): serogroup tested for but not identiﬁed (i.e., 0.0% prevalence). Blank: serogroup not tested for or testing of serogroup not
reported. The most prevalent group identiﬁed is shown in bold.
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vaccinated with a conjugate meningococcal vaccine (range 15–55%
coverage) (Tryﬁnopoulou et al., 2016; Korzeniewski et al., 2015;
Korzeniewski et al., 2017). The age of the participants was reported
in ﬁve of the studies and all were among adults, typically aged 20–
50 years. In the three studies that reported the sex of participants,
the study populations were more than 98% male.
While the swabbing site differed between studies, the methods
for detecting the capsular group were more similar in studies
conducted in military personnel than the previously described
university setting. The site of swabbing varied between studies;
three studies swabbed the nasopharynx and two the pharynx. PCR
was used in all studies to detect the genogroup, except in Turkey
where SASG was used. The study among Korean recruits primarily
used SASG, but used PCR for isolates that could not be
characterized using SASG (Heo et al., 2014).
Carriage was relatively low in most studies, with the highest
carriage rate among Greek new recruits (Table 3). Serogroups A, B,
C, W, X, Y, and non-groupable were identiﬁed in at least one study.
The only study from the Eastern Mediterranean region identiﬁed
serogroup C as the most prominent, while serogroup B was the
most common throughout much of the European region. In the
Western Paciﬁc region, B was the most common at one time point
and non-groupable for the other three.
Three studies investigated risk factors associated with in-
creased meningococcal carriage in military personnel (Supple-
mental material Table S7) (Tryﬁnopoulou et al., 2016;
Korzeniewski et al., 2015; Korzeniewski et al., 2017). Risk factors
investigated in these studies included both demographic data and
social behaviours. Among professional soldiers, both studies found
smoking increased the risk for carriage. One study included both
university students and military recruits in their risk factor
assessment (Tryﬁnopoulou et al., 2016); therefore, these associ-
ations are not reported as it cannot be determined which setting
contributed to the increased risk.
Discussion
It was observed that the majority of carriage studies in high-risk
settings were conducted among university students, with few
studies reporting serogroup data among Hajj pilgrims or military
personnel. It was also observed that the majority of carriage
studies were conducted in the region of the Americas or the
European region. In the three studies among Hajj pilgrims,
serogroup B was the most prevalent across regions. Carriage
was highest among university students compared to the other tworisk groups included in this review, and non-groupable or ‘other’
serogroups were the most prevalent in the majority of studies.
Only ﬁve carriage studies reporting serogroup data were identiﬁed
among military personnel. Carriage was found to be low in most of
these studies, with serogroups B and non-groupable or ‘other’
serogroups being most prevalent.
Several global outbreaks have been associated with the Hajj
pilgrimage, such as the one in 2000 caused by a hyperinvasive W
strain (Jean-François et al., 2002). Protective measures have been
introduced to help protect pilgrims, including a mandatory
quadrivalent vaccine and chemoprophylaxis to clear carriage in
pilgrims from the African meningitis belt (Yezli et al., 2016a). The
study among Turkish pilgrims in 2010 was consistent with results
from the Hajj carriage review from Yezli, Wilder-Smith (Yezli et al.,
2016b) describing serogroups B and W as the most prominent.
However, in the studies identiﬁed from 2014, only serogroup B
predominated among Hajj carriers. This is, perhaps, not surprising
given the mandated quadrivalent (ACWY) vaccine prior to the
pilgrimage—although most pilgrims included in studies in this
review reported receiving the polysaccharide vaccine, which does
not prevent carriage acquisition (Borrow et al., 2016). Continued
research is needed to ascertain whether a broad coverage
serogroup B vaccine is warranted in the future (Memish et al.,
2017).
Carriage was highest in university students, especially students
from the region of the Americas and European region. Interesting-
ly, university students in these regions were the only population to
carry such high levels of non-groupable or ‘other’ serogroups
compared to other high-risk settings and populations in this
review. However, with limited data, it is not possible to say
whether this is simply due to variability within the studies or a
possible explanation for the high carriage levels in this setting.
While most of the carriage was of non-groupable or ‘other’
serogroups, there was still considerable carriage of disease-causing
serogroups in some studies, especially if students were living in
dormitories. Outside of these regions, few studies were conducted,
but reported lower carriage levels compared to the Americas and
Europe. University students should continue to be evaluated as a
potential source of IMD transmission and considered for targeted
vaccination to decrease disease burden.
Few studies were conducted in military personnel and these
were primarily from Europe. Carriage prevalence was less than
previously identiﬁed in this region (Soriano-Gabarro et al., 2011b),
but this is perhaps due to the timing of the studies included in this
review. Most of the studies sampled recruits on day 1 of entry or
professional soldiers who did not live in barracks. Therefore, the
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acquisition. The one study that sampled from the same cohort on
day 1 and again 5 weeks later reported variable results, with
increased overall carriage prevalence in one cohort and decreased
overall carriage prevalence in the other. Notably, the increase in
carriage prevalence among the ﬁrst cohort was primarily due to
increased non-groupable carriage. Additional studies are needed to
determine whether the risk of increased carriage in new recruits
remains.
No single risk factor was universally associated with carriage,
but several were identiﬁed including male sex, attending clubs or
parties at least once a week, and smoking, which are consistent
with the previous literature (MacLennan et al., 2006). Although it
cannot be said with certainty that these risk factors are consistent
in all regions, the ones highlighted in this review can, nonetheless,
be useful to inform public health practice. Knowledge of these risk
factors has encouraged protective meningococcal vaccination in
other at-risk populations, such as Norwegian teenagers participat-
ing in the annual russ celebrations (Norwegian Institute of Public
Health (NIPH), 2017). Policymakers and researchers should
continue to evaluate whether additional groups within their local
demographics share similar risk factors and, thereby, increased
risk of carriage and IMD.
Study design, participant characteristics, laboratory methodolo-
gy, and local epidemiology can all impact the detected carriage
prevalence and the risk factors associated with it. Factors such as
recent antibiotic use and immunization with a conjugate vaccine are
associated with decreased carriage (Borrow et al., 2016; Breakwell
et al., 2018; McNamara et al., 2017b; Soeters et al., 2017), while
outbreaks can occasionally increase carriage rates (Safadi et al.,
2014). Certain methods are more sensitive for detection, such as
swabbing the posterior pharynx instead of the nasopharynx or using
PCR insteadofSASGforgenogroupclassiﬁcation(Roberts etal., 2009;
Borrow, 2012). Therefore, use of these methodologies would be
beneﬁcial when assessing meningococcal carriage. Study design can
also affect the risk factor analyses in studies that have small sample
sizes or unexpectedly low carriage rates, and thus, decreased power
to detect differences. It is advisable that future carriage studies use
methods sensitive for detection and consider local epidemiological
factors when calculating a necessary sample size.
Data gaps by region were prevalent across all settings, with few
studies conducted in the African, Eastern Mediterranean,
South-East Asia, and Western Paciﬁc regions. Additional research
should be considered in these regions to understand how carriage
levels and serogroups in these regions differ from those of the
Americas and the European region. There are several ongoing
studies that will help partially ﬁll this gap. Two studies are among
university students, one in Australia and the other in Japan (trial
registration numbers ACTRN12617000233325 and JPRN-
UMIN000026546, respectively). Additionally, there are two ongo-
ing studies in Hajj pilgrims, one investigating the effect of
quadrivalent conjugate vaccination on carriage in Australian,
Saudi Arabian, and Qatari pilgrims (trial registration number
ACTRN12616001230448) and another assessing before and after
carriage in French pilgrims (trial registration number
NCT02868541).
The strengths of this study include the comprehensive literature
search, including Chinese language databases. Additionally, this
appears to be the ﬁrst review analyzing the serogroup-speciﬁc
carriage in university students and military personnel in regions
outside of Europe and updates a previous review of carriage in Hajj
pilgrims (Yezli et al., 2016b; Soriano-Gabarro et al., 2011b).
However, this review is not without limitations. As with all
systematic reviews, this review was limited by the studies
conducted and the data available. As such, there are considerabledata gaps in many world regions in this review. The methodologies
varied widely among studies, which could have affected the
carriage prevalence detected. Limitations notwithstanding, it is
believed that this review will be beneﬁcial to researchers and
policymakers who wish to gain an understanding of the serogroup-
speciﬁc carriage studies conducted in the previous decade in the
high-risk settings included in this review.
This review provides a comprehensive evaluation of the
serogroup-speciﬁc carriage studies conducted between 2007
and 2016, providing a further understanding of the N. meningitidis
epidemiology in speciﬁc regions and risk groups. There is a need
for more well-designed carriage studies to continue answering
questions about carriage acquisition, transmission, risk factors, and
duration of carriage. This understanding is important for vaccina-
tion policy, as countries may consider vaccinating the portion of
the population with the highest carriage levels, and thus, those
most responsible for transmission (Borrow et al., 2016). Carriage
data, such as those presented in this review, should be used as a
supplement to disease data when developing vaccination policies,
as a low prevalence of carriage does not necessarily correlate with a
decreased risk of disease. This is evident within Africa, where a
large multi-country carriage study found relatively low carriage
prevalence in the region with the highest burden of IMD (Ali et al.,
2015). Further work is also required to assess the efﬁcacy of newly
introduced vaccines to decrease N. meningitidis carriage and
develop indirect herd immunity.
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